新泽西州生物拉戈先进PFAS清洁技术、扩大电池和医疗设备生产,目标是2026年发射。 BioLargo advanced PFAS cleanup tech, expanded battery and medical device production in New Jersey, targeting 2026 launches.

生物拉戈公司在新泽西新泽西市水厂推广了其水电电集中器(AEC)技术,以消除PFAS污染物,发展公私伙伴关系,建立用于家庭能源储存的细胞电池工厂,扩大新泽西的碘基医疗装置制造能力,预定2026年启动。 BioLargo, Inc. advanced its Aqueous Electrostatic Concentrator (AEC) technology at a New Jersey municipal water plant to remove PFAS contaminants, pursued public-private partnerships to build Cellinity battery factories for domestic energy storage, and expanded manufacturing capacity in New Jersey for its iodine-based medical devices, set for a 2026 launch. 这些动作反映出公司关注可持续的系统层面解决方案, 与全球水安全、清洁能源、医疗创新需求不断增长相适应, These moves reflect the company’s focus on sustainable, system-level solutions aligned with growing global demands in water security, clean energy, and healthcare innovation amid rising regulatory and infrastructure challenges.